l /
     

MolecuCare Inc
   The World's Disinfection & Sterilization Leader
        Made in the USA

UV Air & Water Disinfection Technologies and Licensors

 

           

M o l e c u C a r e ®  DISEASE PREVENTION

the world'S MOST POWERFUL ultraviolet IRRADIATION SYSTEMS

HOME

AIR DISINFECTION SYSTEMS

WATER DISINFECTION SYSTEMS

HOSPITAL / CLINICAL / ISOLATION

AIRCRAFT / PUBLIC AREAS

LEASE / PURCHASE INFORMATION

UV IRRADIATION RESEARCH

HISTORY

HVAC / PLUMBING CONTRACTORS

CONTACT MOLECUCARE

 

Ultraviolet Disinfection Technologies: The History & Development of MolecuCare

About the Founder...

History of MolecuCare

The company's initial technology developments were inspired by extensive review of nosocomial or "hospital acquired" infection in 1988. Various explorations into ultraviolet germicidal irradiation led to tests of the company's "Biophysics Germicidal Integration Chamber" at Yale University School of Medicine's Department of Molecular Biophysics and Biochemistry (William Konigsberg, Ph.D., Departmental Chair, presiding) and at the AMSCO Corporation (1992-1994), then the largest U.S. manufacturer of sterilizer and operating room equipment (J.P. Dalmasso, Ph.D., Director of Microbiology, presiding).

Included in the development program was a study of current practices in the use of ultraviolet and a review of current theories and studies involving application of ultraviolet irradiation to sterilization. In addition, a study of infection or "prevention-failure" rates was undertaken: the company focused on method reliability and long term cost effectiveness as the backbone of its technology development. The "A-MOP" first surface' sterilizer developed around MolecuCare's proprietary "Quantum Dose" ultraviolet technology was tested against all other methods, including several high intensity ultraviolet lamps, for sterilization of dental prosthetics, at the Dental School of Loma Linda University. A formal test affidavit report indicated the A-Mop removed all bacteria from tested dental inlays of many configurations; all other ultraviolet irradiation used in the tests failed by considerable margins.

The company developed an ultraviolet germicidal irradiation technology which accelerated the "kill physics" for various airborne vectors, including spores and fungi, while quantifying consistent control parameters, a significant advance in air disinfection standards. By 1995, patented OPTON Mold Removal Air Disinfection Chamber© systems for molecular air disinfection had evolved. Founded in the destruction of airborne microorganisms at the molecular level, the OPTON Chamber uses physics to enhance molecular induced changes with a quantitative control method. Initial roll-away production model consoles - now the Model H-10 AIRGuard Console - were placed in hospital beta sites in New York and Florida in late 1995.

Early roll-away model of the Model H-10 AIRGuard Console in beta site testing in the drug resistant TB/HIV Intensive Care Isolation unit of a Bronx, New York, hospital in 1996.

The H-10 is hospital service rated for 10,000 cubic feet (e.g., a 20 x 50 x 10' space), killing all virus, spore and bacteria including Staphylococcus and the smallest microorganisms not caught in filters. H-10s are used in TB Risk Bay and Emergency Room service, Surgery, and in AIDS-care residences in New York and Florida. H-10 floor consoles were tested in extensive protocols designed to eliminate air movement alone as a contributor to microbe kill by dehydration, Jerry Nelson, Ph.D., presiding, Director of Nelson Laboratories, Salt Lake City, Utah.

The H-10's output ranges of 450/950 CFM feature regular On/Off cycle with room occupancy override or optional auto-selective environment control. Hospital grade components include toggle fusing, heavy duty grounded 115V line cord and 6-caster swivel base plate mounting for safe unit balance and ease of movement. Heavy gauge aluminum construction, weight 210 lbs, quiet needle bearing centrifugal fan, intake air dust filter, services air volume rating in 15 minutes.

Designed for hospital, clinic, physician waiting room, vaccine & health related general service and quarantine, and flu control in any area.

See Hospital / Clinical Systems

One of many early MolecuCare H-10 air disinfection units placed in hospital use in 1996 for initial beta-testing remains in use in 2004.

 

Microbiological warfare tests of the company's first molecular air disinfection equipment (roll-away consoles for clinical use) were completed in 1997. Performed at an independent ISO 9001/EN45001 Certified commercial laboratory, these tests were designed to eliminate the false-positive kill effects of air movement commonly attributed to equipment performance. Each test consisted of ten minute passes of artificially high density challenges of colony-forming viruses, spores, bacteria, and fungi, including Aspergillus niger. Contaminant sizes ranged down to smaller (0.025 micron) than the sieving capabilities of HEPA filters.

The resulting numerous patented disinfection technologies evolved into the OPTON Mold Removal Air Disinfection Chamber and the OPTON system, providing the world's first and only true clinical standard whole building air disinfection capability. Designed for healthcare applications, proven OPTON Chamber use in the system introduced a defense method to the increasing incidence of "sick building" airborne mold spore pollution: Sequential OPTON Chamber roll-in/roll-out "trains" introduced PAR Portable Air Remediation© to provide immediate safe access for "sick building" remediation personnel while central air [forced-air HVAC] systems are being modified for permanent installation of OPTON Chambers in the HVAC systems.

These "microbe incinerator" trains combine multiple Chambers with powerful blowers mounted on mobile platforms, allowing immediate emergency placement and use in any building. The trains can be located as needed throughout a building and used with or without an operating central air system. Leading IAQ [indoor air quality] engineering firms view the OPTON PAR Portable Air Remediation system as an unprecedented tool for emergency indoor air management and preparation.

In 2001, MolecuCare patented the world's first combination water and air disinfection system: in 2003, Canada issued a patent for MolecuCare's new OPTON Chamber (now AstroStream™) water sterilization technology.

About the Founder

MolecuCare was founded by Chicago native Arthur L. Matschke {"match-key"} with a forty-year history of invention, patents and technical achievements in the fields of fiber-optics [Armour Research Foundation, Reactor Section], auto-focus cameras and 35-MM additive color printers, optical tooling for infra-red and aerial reconnaissance, the Powers aerial camera, the T-35 tank fire control, glass & lens manufacturing [Bell & Howell Co.], color TV tube technological improvement [Zenith Radio Corporation], ultra high-speed dot-matrix print head advancements [Baudex Corp.], and numerous related automation & manufacturing processes.

Matschke has also served as a technological consultant to the Buick Division of General Motors, Teletype, Minneapolis Honeywell, Crane, AMF, Ford, General Electric and other companies; he also served as Corporate Director of Product Development at the thirty-one company conglomerate Alloys Unlimited, Inc. As a consultant he oversaw construction of the first paneled glass manufacture air-claving plant in the U.S. at Globe Glass [licensed utilizing the St. Gobain process] to produce panels used globally as structural components in large buildings, as well as panels used for sound proofing at Kennedy Space Center, where one of his patented devices for ‘multi-pin solderless' connectors for space-flight requirements regularly leaves Earth with this essential component aboard.

Arthur L. Matschke, 
              Founder and Principal Scientist of MolecuCare
After a personal surgical experience in 1990, our founder focused on the global problem of inadequate air & surgical implement disinfection plaguing the hospital & healthcare industries, ("nosocomial" or hospital-acquired infections). In the years since, MolecuCare has developed and patented the world's leading air and water disinfection technologies, while also focusing on continued improvement of surgical and dental implement sterilization as well as other hospital, surgical, and intensive care/isolation disinfection and sterilization needs.

Art Matschke also developed an ad hoc sterilization chamber for use in surgical procedures; examples are select organ transplant and foreign element bodily introduction (e.g., Pacemaker, valve, bone joint, invasive dental prosthetic, etc).

This chamber, which he commends as his most rewarding personally, is the world's only instantaneous access-recovery ("instant in and out") sterilization chamber. The six-second cycle chamber, proven in exhaustive independent laboratory tests and studies, is subject to FDA trial completion halted by Matschke during his absence due to illness.

This device was proclaimed by the Loma Linda University Dental School the only "100% kill method, bar none, of dental prosthetics' and dental burr microbe presence". A single mention of this device created the largest volume reader response to date to a dental journal article review... Current information on the MolecuCare six-second-cycle Prosthetix© article disinfection unit is at "Products and Programs Background", here Air Disinfection.

Continuous refinements of other MolecuCare ultraviolet disinfection technologies have resulted in numerous applications, including whole-building clinical grade air disinfection & water sterilization products, and specialized laboratory and mobile emergency bioprotection systems.

Top of Page

© 1997/2010 MolecuCare Inc, Cheyenne, Wyoming 82001 USA